Does VUTRISIRAN Cause Therapeutic response shortened? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Therapeutic response shortened have been filed in association with VUTRISIRAN (AMVUTTRA). This represents 1.7% of all adverse event reports for VUTRISIRAN.
24
Reports of Therapeutic response shortened with VUTRISIRAN
1.7%
of all VUTRISIRAN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapeutic response shortened From VUTRISIRAN?
Of the 24 reports, 2 (8.3%) required hospitalization.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VUTRISIRAN. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does VUTRISIRAN Cause?
Death (244)
Hospitalisation (143)
Intentional dose omission (80)
Therapy interrupted (66)
Fall (65)
Fatigue (56)
Product dose omission issue (45)
Pain in extremity (43)
Dyspnoea (42)
Gait disturbance (42)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
Which VUTRISIRAN Alternatives Have Lower Therapeutic response shortened Risk?
VUTRISIRAN vs VX-950
VUTRISIRAN vs VYVANSE
VUTRISIRAN vs WARFARIN
VUTRISIRAN vs WATER
VUTRISIRAN vs WELLBUTRIN